Amarin Corp Plcuk (AMRN) Operating Expenses (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Operating Expenses of $27.0 million for Q2 2026, down 59.31% year-over-year from $66.3 million in Q2 2025, and down 7.23% quarter-over-quarter from $29.1 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Operating Expenses (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Operating Expenses for 17 consecutive years, with $27.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Expenses fell 59.31% year-over-year to $27.0 million; the TTM figure through Jun 2026 stood at $118.9 million (down 38.27% YoY), while the FY2025 annual figure was $171.0 million, down 1.24% from the prior year.
- Operating Expenses fell to $27.0 million in Q2 2026 per AMRN's latest filing, from $29.1 million in the prior quarter.
- Across five years, Operating Expenses topped out at $106.5 million in Q2 2022 and bottomed at $27.0 million in Q2 2026.
- Historically, Operating Expenses has averaged $54.5 million across 5 years, with a median of $47.7 million in 2023.
- Annual changes were most pronounced in 2025 — Operating Expenses jumped 53.25% — and 2026, when it slumped 59.31%.
- Amarin Corp Plc\Uk's Operating Expenses stood at $73.2 million in 2022, then tumbled by 31.74% to $50.0 million in 2023, then decreased by 14.02% to $43.0 million in 2024, then plunged by 31.34% to $29.5 million in 2025, then retreated by 8.46% to $27.0 million in 2026.
- Business Quant data shows AMRN's Operating Expenses at $27.0 million in Q2 2026, $29.1 million in Q1 2026, and $29.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 6.09 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 9.70 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -7.60 Bn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | 27.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.00 Mn |
| Mar 31, 2026 | 29.10 Mn |
| Dec 31, 2025 | 29.49 Mn |
| Sep 30, 2025 | 33.31 Mn |
| Jun 30, 2025 | 66.35 Mn |
| Mar 31, 2025 | 41.89 Mn |
| Dec 31, 2024 | 42.96 Mn |
| Sep 30, 2024 | 41.44 Mn |
| Jun 30, 2024 | 43.29 Mn |
| Mar 31, 2024 | 45.49 Mn |
| Dec 31, 2023 | 49.96 Mn |
| Sep 30, 2023 | 51.27 Mn |
| Jun 30, 2023 | 66.63 Mn |
| Mar 31, 2023 | 65.27 Mn |
| Dec 31, 2022 | 73.19 Mn |
| Sep 30, 2022 | 68.00 Mn |
| Jun 30, 2022 | 106.46 Mn |
| Mar 31, 2022 | 100.70 Mn |
| Dec 31, 2021 | 97.72 Mn |
| Sep 30, 2021 | 124.90 Mn |